RxDoctor Payments Data

James Ferlmann, MD

Plastic and Reconstructive Surgery · Gilbert, AZNPI 1558369371

Payments from drug & device makers

What this record shows

14 manufacturers reported payments, led by Angiodynamics, Inc. at 58.4% of the total. Reporting peaked in 2021 at $1,813 and has fallen 96.5% since, to $63 in 2025. That places this record below the midpoint for plastic and reconstructive surgery clinicians in AZ, where the typical reported total is $2,637.

$2,826in general payments, 2019–2025

Across 45 payments — averaging $62.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Angiodynamics, Inc.$2K
  • AbbVie$357
  • Kerecis Limited$304
  • Mentor Worldwide LLC$182
  • Next Science LLC$114
  • Smith+Nephew$49
  • plus $170 from 8 others

What the payments were for

  • Food & beverage$1,17642%
  • Education$1,65058%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,826 in reported general payments places this provider in the 50th percentile of 63 plastic and reconstructive surgery providers in Arizona.

See all plastic and reconstructive surgery providers in Arizona

Medicare billing

Part B allowed, 2024
$117,220
Medicare patients
38
Services billed
292

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SsdSilver Sulfadiazine20$277
Silver Sulfadiazine14$112

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Gilbert

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →